The Scottish Medicines Consortium (SMC) has recommended that Ponvory (ponesimod) be offered through the National Health Service (NHS) Scotland to people with active,…
Articles by Patricia Inacio, PhD
Numares has signed an exclusive licensing agreement with Oxford University Innovation to develop and commercialize a panel of…
New preclinical data continues to support the potential of Cyxone’s investigational plant-derived peptide T20K for the treatment of…
The U.S. Patent and Trademark Office will grant Medsenic a patent covering the use of Arscimed, its investigational formulation…
Innodem Neurosciences is teaming up with Novartis Canada on a breakthrough clinical trial to evaluate if Innodem’s digital…
The National Institute for Health and Care Excellence (NICE) will not recommend that Ponvory (ponesimod) be added to the…
Immunic Therapeutics has enrolled the first patient in a Phase 2 clinical trial testing its oral therapy candidate IMU-838…
A partnership will allow NervGen to use Imeka‘s proprietary biomarker imaging technology to precisely measure changes in the brain…
The Accessible Product Design Alliance has released a statement calling for changes in products and packaging design to assure equal…
Temedica, a Munich-based digital health company, has joined efforts with Roche to launch a free mobile app that…
Belong.Life has launched an app that allows health professionals to build and manage their own online communities of…
Moderate-to-severe bowel dysfunction was detected in 14.5% of adult people with multiple sclerosis (MS), an Italian study reports. The…
Meeting people and dating is challenging for people with multiple sclerosis (MS), but the experience of dating is highly…
Jazz Pharmaceuticals is planning to open a third Phase 3 clinical trial of Sativex (nabiximols), an oral…
A natural, small molecule called 3-HKA) has shown potent anti-inflammatory activity in lab tests and mouse models of immune-related diseases,…
Actively taking steps to cope with the chronic stress of multiple sclerosis (MS) — from keeping a sense of…
Three scientists in the U.K. were given awards by the International Progressive MS Alliance that will support projects aiming to…
MediciNova announced that it will be given a U.S. patent covering the use of ibudilast (MN-166) in treating eye…
Sativex (nabiximols), an oral spray that contains cannabis extracts, was found effective as an add-on therapy for easing…
The Multiple Sclerosis Society of Canada has granted its International Progressive MS Alliance (Alliance) Research Challenge Awards to 19…
A home-based rehabilitation program can help ease fatigue, improve motor and cognitive function, and promote better quality of life in…
BurnAlong and the Shepherd Center, a leading rehabilitation hospital in the U.S., have established a partnership to bring tailored…
A clinical trial investigating patient-derived stem cell transplants for the treatment of people with severe relapsing forms of…
MindMaze’s animated ‘games,’ designed to aid in recovering motor and cognitive skills in people with neurological disabilities, such as…
The National Institute for Health and Care Excellence (NICE) has maintained its initial draft recommendation and will not recommend…
A conversational bot is being developed at the University of Illinois at Urbana-Champaign (UIUC) to promote COVID-19 vaccinations among…
Therini Bio announced raising $17 million in a financing round to speed the development of an antibody that might treat…
The Consortium of Multiple Sclerosis Centers (CMSC) has launched a monthly webinar series, in partnership with NeurologyLive, to keep doctors…
The multiple sclerosis (MS) treatment Gilenya (fingolimod) is associated with a 16% greater risk of infections, compared with a…
Kesimpta (ofatumumab) has been approved in the U.K. as the first self-administered, at-home, B-cell-targeting therapy for people with relapsing…